• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植术后一年以后:迟发性机会性感染的流行病学与管理

Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney Transplantation.

作者信息

Esnault V, Hoisnard L, Peiffer B, Fihman V, Fourati S, Angebault C, Champy C, Gallien S, Attias P, Morel A, Grimbert P, Melica G, Matignon M

机构信息

Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Maladies Infectieuses et d'Immunologie Clinique, Centre Hospitalo-Universitaire (CHU) Henri Mondor, Créteil, France.

Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, AP-HP, Henri Mondor Hospital, Créteil, France.

出版信息

Transpl Int. 2024 Feb 26;37:12065. doi: 10.3389/ti.2024.12065. eCollection 2024.

DOI:10.3389/ti.2024.12065
PMID:38468638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10926380/
Abstract

Late opportunistic infections (OI) occurring beyond the first year after kidney transplantation (KT) are poorly described and not targeted by prophylactic strategies. We performed a ten-year retrospective monocentric cohort study describing epidemiology, risk factors and impact of late OI occurring 1 year after KT. We included clinically symptomatic OI requiring treatment besides BK virus nephropathy. Control groups included early OI occurring in the first year after KT, and KT recipients without OI since KT and alive with a functional allograft at 1 year. Among 1066 KT recipients, 185 (19.4%) presented a first episode of OI 21.0 (8.0-45.0) months after KT: 120 late OI (64.9%) and 65 early OI (35.1%). Late OI were mainly viral ( = 83, 69.2%), mostly herpes zoster (HZ) ( = 36, 43.4%). Pneumocystis represented most late fungal infections ( = 12/25, 48%). Compared to early OI, we reported more pneumocystis ( = 0.002) and less invasive aspergillosis ( = 0.01) among late OI. Patients with late OI were significatively younger at KT (54.0 ± 13.3 vs. 60.2 ± 14.3 years, = 0.05). Patient and allograft survival rates between late OI and control groups were similar. Only age was independently associated with mortality. While late OI were not associated with higher mortality or graft loss, implementing prophylactic strategies might prevent such infections.

摘要

肾移植(KT)术后第一年之后发生的晚期机会性感染(OI)鲜有描述,且未被预防性策略所针对。我们进行了一项为期十年的回顾性单中心队列研究,描述KT术后1年发生的晚期OI的流行病学、危险因素及影响。我们纳入了除BK病毒肾病外需要治疗的临床症状性OI。对照组包括KT术后第一年发生的早期OI,以及自KT术后无OI且1年时移植肾功能良好存活的KT受者。在1066例KT受者中,185例(19.4%)在KT术后21.0(8.0 - 45.0)个月出现首次OI发作:120例晚期OI(64.9%)和65例早期OI(35.1%)。晚期OI主要为病毒感染(n = 83,69.2%),大多为带状疱疹(HZ)(n = 36,43.4%)。肺孢子菌是大多数晚期真菌感染的病原体(n = 12/25,48%)。与早期OI相比,晚期OI中肺孢子菌感染更多(P = 0.002),侵袭性曲霉病更少(P = 0.01)。晚期OI患者KT时年龄显著更小(54.0 ± 13.3岁 vs. 60.2 ± 14.3岁,P = 0.05)。晚期OI组与对照组之间的患者及移植肾存活率相似。只有年龄与死亡率独立相关。虽然晚期OI与更高的死亡率或移植肾丢失无关,但实施预防性策略可能预防此类感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5324/10926380/1a4dfe531dbc/ti-37-12065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5324/10926380/acd6b2be55a5/ti-37-12065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5324/10926380/1a4dfe531dbc/ti-37-12065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5324/10926380/acd6b2be55a5/ti-37-12065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5324/10926380/1a4dfe531dbc/ti-37-12065-g002.jpg

相似文献

1
Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney Transplantation.肾移植术后一年以后:迟发性机会性感染的流行病学与管理
Transpl Int. 2024 Feb 26;37:12065. doi: 10.3389/ti.2024.12065. eCollection 2024.
2
Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients.肾移植和肾胰联合移植受者中BK多瘤病毒相关性肾病的血清和尿液核酸筛查试验
Cochrane Database Syst Rev. 2024 Nov 28;11(11):CD014839. doi: 10.1002/14651858.CD014839.pub2.
3
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.用于肾移植受者诱导治疗的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2.
4
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
5
Interventions for BK virus infection in kidney transplant recipients.肾移植受者 BK 病毒感染的干预措施。
Cochrane Database Syst Rev. 2024 Oct 9;10(10):CD013344. doi: 10.1002/14651858.CD013344.pub2.
6
A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation.一项描述腹部器官移植后机会性感染的流行病学及转归的回顾性研究。
Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12691. Epub 2017 May 9.
7
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
8
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
9
Interleukin 2 receptor antagonists for kidney transplant recipients.用于肾移植受者的白细胞介素2受体拮抗剂。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD003897. doi: 10.1002/14651858.CD003897.pub3.
10
Are we disadvantaging smokers by excluding them from kidney transplantation? A single-centre experience and survey of kidney transplantation units.将吸烟者排除在肾移植之外会对他们不利吗?单中心经验及对肾移植单位的调查。
Intern Med J. 2025 Jun;55(6):905-912. doi: 10.1111/imj.16627. Epub 2025 Jan 16.

本文引用的文献

1
Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study.新西兰带状疱疹疫苗对带状疱疹及带状疱疹后神经痛的有效性:一项回顾性队列研究。
Lancet Reg Health West Pac. 2022 Sep 26;31:100601. doi: 10.1016/j.lanwpc.2022.100601. eCollection 2023 Feb.
2
Risk Factors and Outcomes of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study of United States Renal Data System Data.肾移植受者侵袭性曲霉菌病的危险因素和结局:美国肾脏数据系统数据的病例对照研究。
Clin Infect Dis. 2023 Apr 17;76(8):1431-1439. doi: 10.1093/cid/ciac927.
3
Chronic Kidney Failure Provokes the Enrichment of Terminally Differentiated CD8 T Cells, Impairing Cytotoxic Mechanisms After Kidney Transplantation.
慢性肾衰竭促使终末分化的 CD8 T 细胞富集,损害肾移植后的细胞毒性机制。
Front Immunol. 2022 May 3;13:752570. doi: 10.3389/fimmu.2022.752570. eCollection 2022.
4
T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients.T 细胞衰老和 CMV 特异性反应受损与肾移植受者的感染风险相关。
Hum Immunol. 2022 Apr;83(4):273-280. doi: 10.1016/j.humimm.2022.01.016. Epub 2022 Feb 18.
5
Association of Premature Immune Aging and Cytomegalovirus After Solid Organ Transplant.实体器官移植后过早免疫衰老与巨细胞病毒的关联。
Front Immunol. 2021 May 27;12:661551. doi: 10.3389/fimmu.2021.661551. eCollection 2021.
6
Aspergillosis: Epidemiology, Diagnosis, and Treatment.曲霉病:流行病学、诊断与治疗。
Infect Dis Clin North Am. 2021 Jun;35(2):415-434. doi: 10.1016/j.idc.2021.03.008.
7
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).实体器官移植中的侵袭性曲霉菌病:一项西班牙全国队列研究(Diaspersot 研究)中的诊断挑战和结局差异。
Mycoses. 2021 Nov;64(11):1334-1345. doi: 10.1111/myc.13298. Epub 2021 Jul 24.
8
Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors.实体器官移植中的带状疱疹:发病率和危险因素。
Front Immunol. 2021 Mar 18;12:645718. doi: 10.3389/fimmu.2021.645718. eCollection 2021.
9
Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept.在转换为贝利尤单抗后,肾移植受者中 CMV 疾病的发病率和表现形式增加。
Am J Transplant. 2021 Jul;21(7):2448-2458. doi: 10.1111/ajt.16430. Epub 2021 Jan 2.
10
Identification of Predictive Markers and Outcomes of Late-onset Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients.识别肾移植受者迟发性肺孢子菌肺炎的预测标志物和结局。
Clin Infect Dis. 2021 Oct 5;73(7):e1456-e1463. doi: 10.1093/cid/ciaa1611.